Is the 18F-FDG PET/CT the definite resource to detect the recurrence on high-risk thyroid cancer patients?

Arch Endocrinol Metab. 2017 Oct;61(5):411-413. doi: 10.1590/2359-3997000000300.
No abstract available

Publication types

  • Editorial

MeSH terms

  • Fluorodeoxyglucose F18*
  • Humans
  • Neoplasm Recurrence, Local / diagnostic imaging*
  • Positron-Emission Tomography
  • Thyroid Neoplasms / diagnostic imaging*
  • Tomography, X-Ray Computed

Substances

  • Fluorodeoxyglucose F18